Zencir, S., Hsieh, M., Hsu, J., Ergun, Y., Chou, G., Li, T., Teng, S. & Topcu, Z. (2020) Selected ellipticine derivatives, known to target topoisomerase II, suppress the alternative lengthening of telomere (ALT) pathway in telomerase-negative cells. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY , 146(7), 1671-1676.